Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?
/in Dendritic Cells, Glioblastoma, International Publications, IOZK Aktuelles, IOZK Veröffentlichungen /von 2023-07-28 / Transl Cancer Res 2023 Aug;12(8):2224-2228The Viral Knock: Ameliorating Cancer Treatment with Oncolytic Newcastle Disease Virus
/in International Publications, Newcastle Disease Virus /von 2023-07-26 / Life (Basel) 2023 Jul;13(8)Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors
/in Breast Cancer, Dendritic Cells, International Publications /von 2023-07-15 / J Immunol 2023 Jul;211(2):219-228Recent oncolytic virotherapy clinical trials outline a roadmap for the treatment of high-grade glioma
/in Brain Tumors in Children, Glioblastoma, International Publications, Newcastle Disease Virus /von 2023-07-07 / Neurooncol Adv 2023;5(1):vdad081Potential of Personalized Dendritic Cell-Based Immunohybridoma Vaccines to Treat Prostate Cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2023-07-01 / Life (Basel) 2023 Jul;13(7)
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution